SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-042903
Filing Date
2021-08-16
Accepted
2021-08-16 15:11:10
Documents
47
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_cmlifesciences2.htm   iXBRL 10-Q 390986
2 CERTIFICATION f10q0621ex31-1_cmlife2.htm EX-31.1 17468
3 CERTIFICATION f10q0621ex31-2_cmlife2.htm EX-31.2 16925
4 CERTIFICATION f10q0621ex32-1_cmlife2.htm EX-32.1 7324
5 CERTIFICATION f10q0621ex32-2_cmlife2.htm EX-32.2 7117
  Complete submission text file 0001213900-21-042903.txt   2852110

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cmii-20210630.xsd EX-101.SCH 40467
7 XBRL CALCULATION FILE cmii-20210630_cal.xml EX-101.CAL 17841
8 XBRL DEFINITION FILE cmii-20210630_def.xml EX-101.DEF 174403
9 XBRL LABEL FILE cmii-20210630_lab.xml EX-101.LAB 293996
10 XBRL PRESENTATION FILE cmii-20210630_pre.xml EX-101.PRE 178140
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_cmlifesciences2_htm.xml XML 274378
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences II Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40090 | Film No.: 211177207
SIC: 8731 Services-Commercial Physical & Biological Research